Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leopoldo Llorente

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedsideAna Villegas, Fernando A Gonzalez, Leopoldo Llorente, et al.
Circulation Research|September 19, 2014
Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trialPilar Jimenez-Quevedo, Juan Jose Gonzalez-Ferrer, Manel Sabate, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Biologics : Targets & Therapy|August 27, 2009
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedsideAna Villegas, Fernando A Gonzalez, Leopoldo Llorente, et al.
Circulation Research|September 19, 2014
Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trialPilar Jimenez-Quevedo, Juan Jose Gonzalez-Ferrer, Manel Sabate, et al.
Pageof 1